US Supreme Court Human Genome Patents (Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 June 13, 2013 & now in Congress, the 'Patent Eligibility Restoration Act' of 2022/2023) to overturn patenting DNA decision
Fauci, Gates, and Pharma Control the Research Industry and Crack Down on Funding for Chronic Disease Robert Kennedy Jr: "[They control 85 to 90% of the budget]. They do not want anybody doing [research on chronic disease]